Matador Resources (NYSE:MTDR) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight what ...
Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...
The crackle of electricity inside your brain has long been too complex to decode. Artificial intelligence is changing that.
Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in 2026 Partnership on track to deliver ...
Intuitively, these products should work. But they don’t fix any medical problem when measured objectively or compared against placebo.
5d
Alphatec outlines 17% revenue growth target for 2026 while strengthening profitability and cash flow
Q4 2025 earnings call recap: 20% revenue growth, improving EBITDA and free cash flow, plus 2026 guidance to $890M—read now.
Surgeon adoption -- Surgeon user base grew 23% in fiscal Q4 2025 and 20% for the year; incremental adoption and increased ...
Lateral flow immunoassays (LFIAs) provide rapid point-of-care results but lack quantitative capabilities. This study presents a platform technology integrating full-spectrum analysis (400-700 nm) with ...
VTT has developed an immunocomplex antibody-based method that is suitable for the precise and rapid detection of small molecules.
This letter is meant to be a supplement to our earnings release and is being furnished to the Securities and Exchange Commission (SEC) and released to our stockholders simultaneously with our earnings ...
Electrification makes the new Turbo S one of the fastest Porsches ever—rivaling the famed 918 Spyder. Is this Porsche hybrid now a hypercar?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results